- Home
- CLPS vs NRXS Comparison
CLPS vs NRXS Comparison
Compare CLPS & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLPS | NRXS |
|---|---|---|
| Founded | 2005 | 2011 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 25.8M |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CLPS | NRXS |
|---|---|---|
| Price | $0.85 | $2.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 19.4K | ★ 48.8K |
| Earning Date | 10-17-2025 | 11-10-2025 |
| Dividend Yield | ★ 15.38% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $164,481,414.00 | $3,362,320.00 |
| Revenue This Year | N/A | $31.05 |
| Revenue Next Year | N/A | $137.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 15.17 | ★ 36.89 |
| 52 Week Low | $0.82 | $1.33 |
| 52 Week High | $1.88 | $6.20 |
Technical Indicators
Market Signals| Indicator | CLPS | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 57.34 |
| Support Level | $0.84 | $2.63 |
| Resistance Level | $0.90 | $2.78 |
| Average True Range (ATR) | 0.03 | 0.15 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 4.44 | 98.57 |
Price Performance
Historical ComparisonAbout CLPS CLPS Incorporation
CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).